1
Clinical Trials associated with V-330A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older Participants (60 to 79 Years Inclusive).
The goal of this study is to learn whether a new vaccine, V330, is safe and learn how well the body's immune system responds by making antibodies after receiving V330.
100 Clinical Results associated with V-330
100 Translational Medicine associated with V-330
100 Patents (Medical) associated with V-330
100 Deals associated with V-330